• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A3腺苷受体激动剂通过GLI-1和ERK1/2信号通路抑制乳腺癌干细胞的存活。

A3 Adenosine Receptor Agonist Inhibited Survival of Breast Cancer Stem Cells via GLI-1 and ERK1/2 Pathway.

作者信息

Jafari Seyyed Mehdi, Panjehpour Mojtaba, Aghaei Mahmoud, Joshaghani Hamid Reza, Enderami Seyed Ehsan

机构信息

Department of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.

Bioinformatics Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

出版信息

J Cell Biochem. 2017 Sep;118(9):2909-2920. doi: 10.1002/jcb.25945. Epub 2017 May 3.

DOI:10.1002/jcb.25945
PMID:28230290
Abstract

Numerous studies have demonstrated the role of A3 adenosine receptor (A3AR) and signaling pathways in the multiple aspects of the tumor. However, there is a little study about the function of A3AR in the biological processes of cancer stem cells (CSCs). CSCs have a critical role in the maintenance and survival of breast cancer. The aim of current study was to investigate the effect of A3AR agonist on breast cancer stem cells (BCSCs). XTT assay showed antiproliferative effect of A3AR agonist (Cl-IB-MECA) on BCSCs. Our results also demonstrated that A3AR agonist reduces mammosphere formation in a dose-dependent manner. Flow cytometry analysis showed that A3AR agonist induces G1 cell cycle arrest and apoptosis in BCSCs. Western blot assay showed that A3AR agonist inhibits the expression of cell cycle and apoptotic regulatory proteins as well as the expression of ERK1/2 and GLI-1 proteins. Finally, these findings propose that A3AR agonist induces cell cycle arrest and apoptosis in BCSCs by inhibition of ERK1/2 and GLI-1 cascade. J. Cell. Biochem. 118: 2909-2920, 2017. © 2017 Wiley Periodicals, Inc.

摘要

大量研究已证明A3腺苷受体(A3AR)及其信号通路在肿瘤的多个方面所起的作用。然而,关于A3AR在癌症干细胞(CSCs)生物学过程中的功能研究却很少。CSCs在乳腺癌的维持和存活中起着关键作用。本研究的目的是探究A3AR激动剂对乳腺癌干细胞(BCSCs)的影响。XTT分析显示A3AR激动剂(Cl-IB-MECA)对BCSCs具有抗增殖作用。我们的研究结果还表明,A3AR激动剂以剂量依赖的方式减少乳腺球的形成。流式细胞术分析显示,A3AR激动剂可诱导BCSCs的G1期细胞周期阻滞和凋亡。蛋白质免疫印迹分析表明,A3AR激动剂可抑制细胞周期和凋亡调节蛋白的表达,以及ERK1/2和GLI-1蛋白的表达。最后,这些研究结果表明,A3AR激动剂通过抑制ERK1/2和GLI-1级联反应诱导BCSCs的细胞周期阻滞和凋亡。《细胞生物化学杂志》118: 2909 - 2920, 2017。© 2017威利期刊公司

相似文献

1
A3 Adenosine Receptor Agonist Inhibited Survival of Breast Cancer Stem Cells via GLI-1 and ERK1/2 Pathway.A3腺苷受体激动剂通过GLI-1和ERK1/2信号通路抑制乳腺癌干细胞的存活。
J Cell Biochem. 2017 Sep;118(9):2909-2920. doi: 10.1002/jcb.25945. Epub 2017 May 3.
2
Effects of synthetic A3 adenosine receptor agonists on cell proliferation and viability are receptor independent at micromolar concentrations.合成 A3 腺苷受体激动剂在微摩尔浓度下对细胞增殖和活力的影响与受体无关。
J Physiol Biochem. 2013 Sep;69(3):405-17. doi: 10.1007/s13105-012-0222-7. Epub 2012 Nov 27.
3
Apoptosis and cell cycle regulatory effects of adenosine by modulation of GLI-1 and ERK1/2 pathways in CD44 and CD24 breast cancer stem cells.腺苷通过调节CD44和CD24乳腺癌干细胞中的GLI-1和ERK1/2信号通路对细胞凋亡和细胞周期的调控作用
Cell Prolif. 2017 Aug;50(4). doi: 10.1111/cpr.12345. Epub 2017 Mar 29.
4
A2B adenosine receptor agonist induces cell cycle arrest and apoptosis in breast cancer stem cells via ERK1/2 phosphorylation.A2B 腺苷受体激动剂通过 ERK1/2 磷酸化诱导乳腺癌干细胞的细胞周期停滞和凋亡。
Cell Oncol (Dordr). 2018 Feb;41(1):61-72. doi: 10.1007/s13402-017-0359-z. Epub 2017 Dec 7.
5
A3 adenosine receptor agonist induce G1 cell cycle arrest via Cyclin D and cyclin-dependent kinase 4 pathways in OVCAR-3 and Caov-4 cell lines.A3腺苷受体激动剂通过细胞周期蛋白D和细胞周期蛋白依赖性激酶4途径诱导OVCAR-3和Caov-4细胞系的G1期细胞周期停滞。
J Cancer Res Ther. 2017 Jan-Mar;13(1):107-112. doi: 10.4103/0973-1482.199381.
6
An adenosine A3 receptor agonist inhibits DSS-induced colitis in mice through modulation of the NF-κB signaling pathway.一种腺苷 A3 受体激动剂通过调节 NF-κB 信号通路抑制右旋糖酐硫酸钠(DSS)诱导的小鼠结肠炎。
Sci Rep. 2015 Mar 12;5:9047. doi: 10.1038/srep09047.
7
A novel adenosine analog, thio-Cl-IB-MECA, induces G0/G1 cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells.一种新型腺苷类似物,硫代-Cl-IB-MECA,可诱导人早幼粒细胞白血病HL-60细胞发生G0/G1期细胞周期阻滞并凋亡。
Biochem Pharmacol. 2005 Sep 15;70(6):918-24. doi: 10.1016/j.bcp.2005.06.017.
8
Adenosine A3 receptor activation inhibits pronociceptive N-type Ca2+ currents and cell excitability in dorsal root ganglion neurons.腺苷 A3 受体的激活抑制背根神经节神经元中的伤害性 N 型 Ca2+ 电流和细胞兴奋性。
Pain. 2019 May;160(5):1103-1118. doi: 10.1097/j.pain.0000000000001488.
9
Cl-IB-MECA inhibits human thyroid cancer cell proliferation independently of A3 adenosine receptor activation.Cl-IB-MECA可独立于A3腺苷受体激活抑制人甲状腺癌细胞增殖。
Cancer Biol Ther. 2008 Feb;7(2):278-84. doi: 10.4161/cbt.7.2.5301. Epub 2007 Nov 14.
10
Adenosine A3 Receptor Mediates ERK1/2- and JNK-Dependent TNF-α Production in Toxoplasma gondii-Infected HTR8/SVneo Human Extravillous Trophoblast Cells.腺苷A3受体介导弓形虫感染的HTR8/SVneo人绒毛外滋养层细胞中ERK1/2和JNK依赖性肿瘤坏死因子-α的产生。
Korean J Parasitol. 2020 Aug;58(4):393-402. doi: 10.3347/kjp.2020.58.4.393. Epub 2020 Aug 25.

引用本文的文献

1
Adenosine Concentration Determination for Tumor Microenvironment Simulation.用于肿瘤微环境模拟的腺苷浓度测定
Dose Response. 2025 Aug 25;23(3):15593258251371484. doi: 10.1177/15593258251371484. eCollection 2025 Jul-Sep.
2
Unlocking the adenosine receptor mechanism of the tumour immune microenvironment.解锁肿瘤免疫微环境中的腺苷受体机制。
Front Immunol. 2024 Jun 27;15:1434118. doi: 10.3389/fimmu.2024.1434118. eCollection 2024.
3
Multifactoral immune modulation potentiates durable remission in multiple models of aggressive malignancy.
多因素免疫调节可增强侵袭性恶性肿瘤多种模型中的持久缓解。
FASEB J. 2024 May 31;38(10):e23644. doi: 10.1096/fj.202302675R.
4
Adenosine receptors in breast cancer.乳腺癌中的腺苷受体。
Mol Biol Rep. 2024 Mar 29;51(1):464. doi: 10.1007/s11033-024-09382-z.
5
Mycochemicals against Cancer Stem Cells.抗癌症干细胞的化感物质。
Toxins (Basel). 2023 May 25;15(6):360. doi: 10.3390/toxins15060360.
6
2‑Cl‑IB‑MECA regulates the proliferative and drug resistance pathways, and facilitates chemosensitivity in pancreatic and liver cancer cell lines.2-氯-N-(异丙基)-烟酰胺通过调节增殖和耐药途径,增强胰腺和肝癌细胞系的化疗敏感性。
Int J Mol Med. 2022 Mar;49(3). doi: 10.3892/ijmm.2022.5086. Epub 2022 Jan 18.
7
Current Adenosinergic Therapies: What Do Cancer Cells Stand to Gain and Lose?当前的腺苷能疗法:癌细胞将何去何从?
Int J Mol Sci. 2021 Nov 22;22(22):12569. doi: 10.3390/ijms222212569.
8
Galectin-9 inhibits cell proliferation and induces apoptosis in Jurkat and KE-37 acute lymphoblastic leukemia cell lines caspase-3 activation.半乳糖凝集素-9抑制Jurkat和KE-37急性淋巴细胞白血病细胞系中的细胞增殖并诱导凋亡,激活半胱天冬酶-3。
Res Pharm Sci. 2021 Oct 15;16(6):612-622. doi: 10.4103/1735-5362.327507. eCollection 2021 Dec.
9
A Adenosine and P2X7 Purinergic Receptors as New Targets for an Innovative Pharmacological Therapy of Malignant Pleural Mesothelioma.A 腺苷和P2X7嘌呤能受体作为恶性胸膜间皮瘤创新药物治疗的新靶点。
Front Oncol. 2021 Oct 1;11:679285. doi: 10.3389/fonc.2021.679285. eCollection 2021.
10
Physalin A, 13,14-Seco-16, 24-Cyclo-Steroid, Inhibits Stemness of Breast Cancer Cells by Regulation of Hedgehog Signaling Pathway and Yes-Associated Protein 1 (YAP1).黄甾酮 A,13,14-去氢-16,24-环甾体,通过调控 Hedgehog 信号通路和 Yes 相关蛋白 1(YAP1)抑制乳腺癌细胞干性。
Int J Mol Sci. 2021 Aug 13;22(16):8718. doi: 10.3390/ijms22168718.